Back to the search results

St. Bernhard-Hospital gemeinnützige GmbH

St. Bernhard-Hospital gemeinnützige GmbH
St. Bernhard-Hospital gemeinnützige GmbH

Claußenstraße 3
26919 Brake

Phone: 04401-105-0
Mail: ed.ekarb-suahneknark@ofni

  • Number of beds: 103
  • Number of specialist departments: 6
  • Number of inpatient cases: 5.638
  • Number of outpatient cases: 14.494
  • Hospital owners: Milde Stiftung St. Bernhard-Hospital, Brake
  • Type of provider: freigemeinnützig
External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
Quantity performed 102
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 102
Quantity forecast year: 100
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
  • Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
    No participation
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: no
Number Group
32 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
27 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
25 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

  • Is a protection concept in place? Yes
  • No care for children and young people
Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission
  • Fallbesprechungen
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Der Chefarzt der Kardiologie und Angiologie, Dr. med. Andreas Reents besitzt einen Lehrauftrag an der Jade Hochschule, in Wilhelmshaven für den Fachbereich Physiologie.

Explanation

Famulanten können im Rahmen ihres Studiums ihre Famulatur in der Klinik zu absolvieren. Zudem besteht eine Kooperation mit der Hochschule Bremerhaven im Rahmen des Studiengangs Physician Assistant. Die Studenten können im Rahmen ihres praktischen Ausbildungsabschnitt hier ausgebildet werden.

Explanation

Der Chefarzt der Klinik für Hämatologie und internistische Onkologie besitzt einen Lehrauftrag für das Fachgebiet der Hämatologie/Onkologie an der Universität Oldenburg. Zu dem publiziert er regelmäßig auf wissenschaftlichen Kongressen und in Fachzeitschriften.

Training in other healing professions
Comment

Ausbildung erfolgt in Kooperation mit dem Pflegeausbildungszentrum am St. Johannes-Hospital in Varel und seit August 2022 in Kooperation mit der Berufsfachschule Pflege in Brake (BBS für den Landkreis Wesermarsch)

Comment

Die Ausbildung erfolgt in Kooperation mit dem Hanse Institut Oldenburg

Comment

Die Ausbildung erfolgt in Kooperation mit dem Pflegeausbildungszentrum am St. Johannes-Hospital gGmbH in Varel.

Martina Kerle

stellvertretende Patientenfürsprecherin

Claußenstraße 3
26919 Brake

Phone: 04401 -105-801
Mail: ed.ekarb-suahneknark@rehcerpsreufnetneitap

Edith Rapedius

Patientenfürsprecher

Claußenstraße 3
26919 Brake

Phone: 04401 -105-801
Mail: ed.ekarb-suahneknark@rehcerpsreufnetneitap

Maxi Krahl-Weigang

Unternehmenskommunikation und Öffentlichkeitsarbeit

Claußenstraße 3
26919 Brake

Phone: 04401 -105-808
Mail: ed.ekarb-suahneknark@ofni

Denise Schindler

Qualitäts- und Risikomanagement

Claußenstraße 3
26919 Brake

Phone: 04401 -105-0
Mail: ed.ekarb-suahneknark@reldnihcs.esined

Dr. med. Thorsten Austein

Ärztlicher Direktor, CA der Medizinischen Klinik II, Hämatologie, intern. Onkologie

Claußenstraße 3
26919 Brake

Phone: 04401 -105-142
Mail: ed.ekarb-suahneknark@nietsua.netsroht.rd

Dr. med. Thorsten Austein

Ärztlicher Direktor / Chefarzt Hämatologie/internistische Onkologie

Claußenstraße 3
26919 Brake

Phone: 04401 -105-141
Mail: ed.ekarb-suahneknark@nietsua.netsroht.rd

Natalia Bischoff

Schwerbehindertenbeauftragte / Empfang

Claußenstraße 3
26919 Brake

Phone: 04401 -105-0
Mail: ed.ekarb-suahneknark@vam

Herr Dirk Schrage

Pflegedienstleitung

Claußenstraße 3
26919 Brake

Phone: 04401 -105-0
Mail: ed.ekarb-suahneknark@egarhcs.krid

Herr Ingo Penner

Geschäftsführung

Claußenstraße 3
26919 Brake

Phone: 04401 -105-201
Mail: ed.ekarb-suahneknark@rennep.ogni

Ingo Penner

Geschäftsführer

Claußenstraße 3
26919 Brake

Phone: 04401 -105-0
Mail: ed.ekarb-suahneknark@rennep.ogni

Dr. med. Thorsten Austein

Chefarzt Hämatologie und Internistische Onkologie

Claußenstraße 3
26919 Brake

Phone: 04401 -105-142
Mail: ed.ekarb-suahneknark@nietsua.netsroht.rd

IK: 260340249

Location number: 772806000

Old location number: 772806000